UMB Financial Corporation · UMBF · FY2025 Q4 · Calendar Q1 2026

UMB Financial posts record earnings as loan growth and Heartland synergies support results

The quarter’s record earnings, 13% annualized loan growth, stable core net interest margin and reported Heartland integration progress support a constructive near-term operating picture. The evidence to monitor is whether loan growth remains sustainable without materially higher costs, and whether margins and credit quality hold as rates and loan balances change.

Reported After market closeNASDAQFinancial Services $10.21B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.08 Consensus $2.71
EPS surprise +13.7% Reported versus consensus
Reported revenue $720.9M Consensus $677.8M
Revenue surprise +6.4% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -0.2% Event window
SPY move -0.0% Same window
Abnormal move -0.2% Stock minus SPY
Volume 2.7× Versus trailing sessions
Subsequent drift -0.7% Up to 20 sessions
UMBFSPY benchmark

Ask FN2 about UMBF FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the latest call describes stronger loan production ($2.6 billion for the quarter, 13% annualized growth), an improved efficiency ratio of 55.5%, and a stable core net interest margin. Management also said acquisition cost-saving measures were fully realized; the prior call had described additional savings expected in Q1 2026. The analysis continues to characterize management as confident and focused primarily on organic expansion.

Guidance delta

No formal guidance was provided in the supplied transcript analysis. The analysis describes management’s margin and growth outlook as not provided, so a quantified change in guidance cannot be established.

Key takeaways

  • Record earnings accompanied loan production of $2.6 billion, or 13% annualized growth.
  • The efficiency ratio improved to 55.5%, while core net interest margin remained stable.
  • Management said Heartland acquisition cost-saving measures were fully realized and cited cross-sell opportunities.
  • The analysis characterizes asset quality as high, with charge-offs below historical averages.
  • Management favors organic growth while remaining open to small tuck-in acquisitions.

Management priorities

  • Continue organic expansion and deepen presence in underserved markets.
  • Develop mortgage and credit-card products in newly acquired markets.
  • Grow fund services, private wealth and trust processing.
  • Consider only tuck-in acquisitions that meet management’s stated cultural criteria.

Follow UMBF with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
UMBF EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $2.01 Q2 '24 actual $2.07, beat Q3 '24 estimate $2.20 Q3 '24 actual $2.19, match Q2 '25 estimate $2.37 Q2 '25 actual $2.96, beat Q3 '25 estimate $2.50 Q3 '25 actual $2.70, beat Q4 '25 estimate $2.71 Q4 '25 actual $3.08, beat Q1 '26 estimate $2.82 Q1 '26 actual $3.41, beat Q2 '26 estimate $3.12 Q2 '26 actual $3.57, beat Q3 '26 estimate $3.22 Q3 '26 actual $3.56, beat Q4 '26 estimate $3.29 Q1 '27 estimate $3.28 Q2 '27 estimate $3.50 Q3 '27 estimate $3.62
Show 2 more >

Analyst Consensus ?

ConsensusBuy19 ratings
Bullish1157.9%
Neutral842.1%
Bearish00.0%

Analyst 52W Price Targets

$134.47Current
$110Low
$160.37Average
$190High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
TD Cowen Buy BuyMaintainOct 29, 2026
Piper Sandler Overweight OverweightMaintainOct 29, 2026
Citigroup Neutral NeutralMaintainOct 29, 2026
Truist Securities Buy BuyMaintainOct 20, 2026
RBC Capital Outperform OutperformMaintainOct 9, 2026
JP Morgan Overweight OverweightMaintainOct 1, 2026
Wells Fargo Equal Weight Equal WeightMaintainSep 30, 2026
Morgan Stanley Overweight OverweightMaintainSep 28, 2026
Barclays Overweight OverweightMaintainAug 3, 2026
Keefe, Bruyette & Woods Outperform OutperformMaintainJul 30, 2026
Raymond James Strong Buy Strong BuyMaintainOct 30, 2025
Janney Montgomery Scott Buy NeutralUpgradeOct 26, 2023
Bank of America Neutral BuyDowngradeJan 10, 2019
B of A Securities Neutral BuyDowngradeJan 10, 2019
PiperJaffray Neutral NeutralMaintainFeb 2, 2018
FBR Capital Perform Market PerformMaintainJan 10, 2017
Keefe Bruyette & Woods Market Perform Market PerformMaintainJul 28, 2016
Sterne Agee Buy BuyMaintainMay 18, 2012
FIG Partners Market Perform Market PerformMaintainApr 30, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $134.47. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Piper SandlerNathan Race$169$132.34 +25.7%Oct 29, 2026
RBC CapitalJon Arfstrom$168$129.86 +24.9%Oct 9, 2026
Wells FargoAnalyst unavailable$147$131.84 +9.3%Sep 29, 2026
Morgan StanleyBrian Wilczynski$182$134.8 +35.3%Sep 28, 2026
UBSAnalyst unavailable$155$139.49 +15.3%Sep 14, 2026
Morgan StanleyAnalyst unavailable$190$143.76 +41.3%Sep 8, 2026
Raymond JamesDavid Feaster$165$144.54 +22.7%Aug 27, 2026
Wells FargoTerry McEvoy$160$145.6 +19.0%Aug 10, 2026
Truist FinancialBrian Foran$170$147.04 +26.4%Aug 4, 2026
BarclaysAnalyst unavailable$175$145.73 +30.1%Aug 3, 2026
RBC CapitalAnalyst unavailable$170$147.52 +26.4%Jul 30, 2026
Piper SandlerAnalyst unavailable$181$148.27 +34.6%Jul 30, 2026
StephensBrandon Rud$167$142.61 +24.2%Jul 14, 2026
Truist FinancialAnalyst unavailable$161$144.53 +19.7%Jul 10, 2026
Wells FargoAnalyst unavailable$139$143.8 +3.4%Jul 6, 2026
Morgan StanleyAnalyst unavailable$159$142.84 +18.2%Jun 29, 2026
Piper SandlerAnalyst unavailable$161$143.41 +19.7%Jun 26, 2026
Neuberger BermanBrandon Berman$152$128.9 +13.0%May 4, 2026
Truist FinancialAnalyst unavailable$140$128.64 +4.1%May 1, 2026
RBC CapitalAnalyst unavailable$142$124.95 +5.6%Apr 30, 2026
Piper SandlerAnalyst unavailable$155$124.22 +15.3%Apr 30, 2026
BarclaysAnalyst unavailable$170$124.22 +26.4%Apr 30, 2026
Truist FinancialBrian Foran$150$126.6 +11.5%Jan 30, 2026
Raymond JamesAnalyst unavailable$145$124.66 +7.8%Jan 29, 2026
Piper SandlerAnalyst unavailable$152$124.66 +13.0%Jan 29, 2026
BarclaysAnalyst unavailable$160$124.66 +19.0%Jan 29, 2026
RBC CapitalJon Arfstrom$134$119.51 -0.3%Jan 12, 2026
Piper SandlerAnalyst unavailable$145$108.68 +7.8%Oct 30, 2025
RBC CapitalJon Arfstrom$128$118.67 -4.8%Oct 10, 2025
BarclaysAnalyst unavailable$155$118.39 +15.3%Oct 8, 2025
Morgan StanleyAnalyst unavailable$154$119.43 +14.5%Sep 29, 2025
Wells FargoAnalyst unavailable$130$119.43 -3.3%Sep 29, 2025
BarclaysJared Shaw$150$110.8 +11.5%Jul 31, 2025
Neuberger BermanBrandon Berman$124$110.21 -7.8%Jul 13, 2025
Truist FinancialBrian Foran$128$110.21 -4.8%Jul 11, 2025
Piper SandlerNathan Race$135$100.7 +0.4%Jun 13, 2025
Wells FargoTimur Braziler$110$97.78 -18.2%May 1, 2025
Neuberger BermanBrandon Berman$105$91.05 -21.9%Apr 16, 2025
Morgan StanleyBrian Wilczynski$156$93.35 +16.0%Nov 21, 2024
BarclaysJared Shaw$123$111.14 -8.5%Oct 31, 2024
CitigroupBenjamin Gerlinger$130$111.14 -3.3%Oct 31, 2024
BarclaysJared Shaw$118$103.62 -12.2%Sep 26, 2024
BarclaysJared Shaw$114$102.02 -15.2%Aug 1, 2024
BarclaysJared Shaw$100$79.6 -25.6%Jun 24, 2024
BarclaysJared Shaw$95$77.75 -29.4%Apr 30, 2024
Wells FargoTimur Braziler$90$77.75 -33.1%Apr 30, 2024
Raymond JamesAnalyst unavailable$110$90.32 -18.2%Jul 28, 2022
Raymond JamesAnalyst unavailable$108$88.75 -19.7%Jul 7, 2022
Wells FargoAnalyst unavailable$100$92.02 -25.6%Apr 28, 2022
Raymond JamesAnalyst unavailable$113$94.58 -16.0%Apr 28, 2022
Show less

Track every rating change on UMBF the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

UMB Financial Corporation serves as the holding company for UMB Bank, delivering a comprehensive array of banking and financial solutions. Its Commercial Banking division provides businesses with essential services, including commercial loans, credit cards, and real estate financing. This segment also offers letters of credit, loan syndication, and consultative support. Furthermore, it delivers specialized business solutions such as asset-based lending, accounts receivable financing, mezzanine debt, and minority equity investments. Comprehensive treasury management services are also available, encompassing depository functions, account reconciliation, cash management tools, accounts payable and receivable solutions, electronic funds transfers, automated payments, controlled disbursements, lockbox services, and remote deposit capture. The Institutional Banking division caters specifically to institutional clients, offering asset management and healthcare services.…

Historical context

All UMBF earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the UMBF recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-11-02T04:00:40.484502+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T04:00:40.481792+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.